C109H111N41O7 — CID 158152827
N-but-1-en-2-yl-6-[[1-(1-methyltetrazol-5-yl)benzimidazol-2-yl]oxymethyl]pyridin-2-amine;N-(1-cyclohexylethenyl)-6-[[1-(1-methyltetrazol-5-yl)benzimidazol-2-yl]oxymethyl]pyridin-2-amine;N-(3-ethylpent-1-en-2-yl)-6-[[1-(1-methyltetrazol-5-yl)benzimidazol-2-yl]oxymethyl]pyridin-2-amine;N-[1-(4-methoxyphenyl)ethenyl]-6-[[1-(1-methyltetrazol-5-yl)benzimidazol-2-yl]oxymethyl]pyridin-2-amine;N-[6-[[1-(1-methyltetrazol-5-yl)benzimidazol-2-yl]oxymethyl]-2-pyridinyl]pyridine-2-carboxamide (PubChem CID 158152827) has the molecular formula C109H111N41O7 and a molecular weight of 2107.37 g/mol. Its IUPAC name is N-but-1-en-2-yl-6-[[1-(1-methyltetrazol-5-yl)benzimidazol-2-yl]oxymethyl]pyridin-2-amine;N-(1-cyclohexylethenyl)-6-[[1-(1-methyltetrazol-5-yl)benzimidazol-2-yl]oxymethyl]pyridin-2-amine;N-(3-ethylpent-1-en-2-yl)-6-[[1-(1-methyltetrazol-5-yl)benzimidazol-2-yl]oxymethyl]pyridin-2-amine;N-[1-(4-methoxyphenyl)ethenyl]-6-[[1-(1-methyltetrazol-5-yl)benzimidazol-2-yl]oxymethyl]pyridin-2-amine;N-[6-[[1-(1-methyltetrazol-5-yl)benzimidazol-2-yl]oxymethyl]-2-pyridinyl]pyridine-2-carboxamide.
| Compound Name | N-but-1-en-2-yl-6-[[1-(1-methyltetrazol-5-yl)benzimidazol-2-yl]oxymethyl]pyridin-2-amine;N-(1-cyclohexylethenyl)-6-[[1-(1-methyltetrazol-5-yl)benzimidazol-2-yl]oxymethyl]pyridin-2-amine;N-(3-ethylpent-1-en-2-yl)-6-[[1-(1-methyltetrazol-5-yl)benzimidazol-2-yl]oxymethyl]pyridin-2-amine;N-[1-(4-methoxyphenyl)ethenyl]-6-[[1-(1-methyltetrazol-5-yl)benzimidazol-2-yl]oxymethyl]pyridin-2-amine;N-[6-[[1-(1-methyltetrazol-5-yl)benzimidazol-2-yl]oxymethyl]-2-pyridinyl]pyridine-2-carboxamide |
|---|---|
| PubChem CID | 158152827 |
| Molecular Formula | C109H111N41O7 |
| Molecular Weight | 2107.37 g/mol |
| Exact Mass | 2105.96 |
| IUPAC Name | N-but-1-en-2-yl-6-[[1-(1-methyltetrazol-5-yl)benzimidazol-2-yl]oxymethyl]pyridin-2-amine;N-(1-cyclohexylethenyl)-6-[[1-(1-methyltetrazol-5-yl)benzimidazol-2-yl]oxymethyl]pyridin-2-amine;N-(3-ethylpent-1-en-2-yl)-6-[[1-(1-methyltetrazol-5-yl)benzimidazol-2-yl]oxymethyl]pyridin-2-amine;N-[1-(4-methoxyphenyl)ethenyl]-6-[[1-(1-methyltetrazol-5-yl)benzimidazol-2-yl]oxymethyl]pyridin-2-amine;N-[6-[[1-(1-methyltetrazol-5-yl)benzimidazol-2-yl]oxymethyl]-2-pyridinyl]pyridine-2-carboxamide |
| SMILES | C=C(CC)Nc1cccc(COc2nc3ccccc3n2-c2nnnn2C)n1.C=C(Nc1cccc(COc2nc3ccccc3n2-c2nnnn2C)n1)C(CC)CC.C=C(Nc1cccc(COc2nc3ccccc3n2-c2nnnn2C)n1)C1CCCCC1.C=C(Nc1cccc(COc2nc3ccccc3n2-c2nnnn2C)n1)c1ccc(OC)cc1.Cn1nnnc1-n1c(OCc2cccc(NC(=O)c3ccccn3)n2)nc2ccccc21 |
| InChI | InChI=1S/C24H22N8O2.C23H26N8O.C22H26N8O.C21H17N9O2.C19H20N8O/c1-16(17-11-13-19(33-3)14-12-17)25-22-10-6-7-18(26-22)15-34-24-27-20-8-4-5-9-21(20)32(24)23-28-29-30-31(23)2;1-16(17-9-4-3-5-10-17)24-21-14-8-11-18(25-21)15-32-23-26-19-12-6-7-13-20(19)31(23)22-27-28-29-30(22)2;1-5-16(6-2)15(3)23-20-13-9-10-17(24-20)14-31-22-25-18-11-7-8-12-19(18)30(22)21-26-27-28-29(21)4;1-29-20(26-27-28-29)30-17-10-3-2-8-15(17)24-21(30)32-13-14-7-6-11-18(23-14)25-19(31)16-9-4-5-12-22-16;1-4-13(2)20-17-11-7-8-14(21-17)12-28-19-22-15-9-5-6-10-16(15)27(19)18-23-24-25-26(18)3/h4-14H,1,15H2,2-3H3,(H,25,26);6-8,11-14,17H,1,3-5,9-10,15H2,2H3,(H,24,25);7-13,16H,3,5-6,14H2,1-2,4H3,(H,23,24);2-12H,13H2,1H3,(H,23,25,31);5-11H,2,4,12H2,1,3H3,(H,20,21) |
| InChIKey | FVIDEVKAKXNDHQ-UHFFFAOYSA-N |
| XLogP | 16.56 |
| TPSA | 517.04 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 47 |
| Rotatable Bonds | 37 |
| Heavy Atoms | 157 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2107.37 |
| LogP ≤ 5 | 16.56 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 47 |